Hot Features
Premium
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Stevanato Group SpA | STVN | NYSE | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 17.77 | 06:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 17.77 |
| Trades | Shares Traded | Average Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 17.66 - 36.30 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| - | 0 | US$ 17.77 | USD |
Stevanato Group SpA Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 5.25B | 295.54M | - | 1.1B | 145.63M | 0.49 | 36.06 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Stevanato News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical STVN Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 18.60 | 19.17 | 17.66 | 18.20 | 484,642 | -0.83 | -4.46% |
| 1 Month | 20.69 | 22.36 | 17.66 | 19.22 | 554,127 | -2.92 | -14.11% |
| 3 Months | 31.39 | 33.49 | 17.66 | 23.40 | 591,424 | -13.62 | -43.39% |
| 6 Months | 28.54 | 34.73 | 17.66 | 25.91 | 438,875 | -10.77 | -37.74% |
| 1 Year | 32.15 | 36.30 | 17.66 | 27.72 | 384,565 | -14.38 | -44.73% |
| 3 Years | 16.65 | 36.30 | 13.355 | 22.92 | 377,835 | 1.12 | 6.73% |
| 5 Years | 16.65 | 36.30 | 13.355 | 22.92 | 377,835 | 1.12 | 6.73% |
Stevanato Description
| Italy-based Stevanato Group is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. Stevanato's revenue is geographically diversified, with 60% of sales from Europe, the Middle East and Africa (EMEA), 27% in North America, 10% in Asia-Pacific (APAC), and 3% in South America. |
